Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB) –the Canadian based leading global medical cannabis ...
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Robert F. Kennedy Jr., seen as pro-cannabis, is heading toward expected approval as Health and Human Services secretary, ...
Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...
TD Securities raised the firm’s price target on Aurora Cannabis (ACB) to C$10 from C$9 and keeps a Buy rating on the shares.Maximize Your ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback